Smith DC - Search Results

1

Lord MJ, Jolliffe NA, Marsden CJ, Pateman CS, Smith DC, Spooner RA, Watson PD, Roberts LM. Lord MJ, et al. Among authors: smith dc. Toxicol Rev. 2003;22(1):53-64. doi: 10.2165/00139709-200322010-00006. Toxicol Rev. 2003. PMID: 14579547 Review.

2

Protein disulphide-isomerase reduces ricin to its A and B chains in the endoplasmic reticulum.

Spooner RA, Watson PD, Marsden CJ, Smith DC, Moore KA, Cook JP, Lord JM, Roberts LM. Spooner RA, et al. Among authors: smith dc. Biochem J. 2004 Oct 15;383(Pt 2):285-93. doi: 10.1042/BJ20040742. Biochem J. 2004. PMID: 15225124 Free PMC article.

3

Insertional mutagenesis of ricin A chain: a novel route to an anti-ricin vaccine.

Marsden CJ, Knight S, Smith DC, Day PJ, Roberts LM, Phillips GJ, Lord JM. Marsden CJ, et al. Among authors: smith dc. Vaccine. 2004 Jul 29;22(21-22):2800-5. doi: 10.1016/j.vaccine.2004.01.024. Vaccine. 2004. PMID: 15246614

4

Lack of dendritic cell maturation by the plant toxin ricin.

Smith DC, Salio M, Lord JM, Roberts LM, Cerundolo V. Smith DC, et al. Eur J Immunol. 2004 Aug;34(8):2149-57. doi: 10.1002/eji.200425157. Eur J Immunol. 2004. PMID: 15259012 Free article.

5

Ricin: the endoplasmic reticulum connection.

Roberts LM, Smith DC. Roberts LM, et al. Among authors: smith dc. Toxicon. 2004 Oct;44(5):469-72. doi: 10.1016/j.toxicon.2004.07.002. Toxicon. 2004. PMID: 15450920 Review.

6

Ricin: current understanding and prospects for an antiricin vaccine.

Marsden CJ, Smith DC, Roberts LM, Lord JM. Marsden CJ, et al. Among authors: smith dc. Expert Rev Vaccines. 2005 Apr;4(2):229-37. doi: 10.1586/14760584.4.2.229. Expert Rev Vaccines. 2005. PMID: 15889996 Free article. Review.

7

The low lysine content of ricin A chain reduces the risk of proteolytic degradation after translocation from the endoplasmic reticulum to the cytosol.

Deeks ED, Cook JP, Day PJ, Smith DC, Roberts LM, Lord JM. Deeks ED, et al. Among authors: smith dc. Biochemistry. 2002 Mar 12;41(10):3405-13. doi: 10.1021/bi011580v. Biochemistry. 2002. PMID: 11876649

8

Exogenous peptides delivered by ricin require processing by signal peptidase for transporter associated with antigen processing-independent MHC class I-restricted presentation.

Smith DC, Gallimore A, Jones E, Roberts B, Lord JM, Deeks E, Cerundolo V, Roberts LM. Smith DC, et al. J Immunol. 2002 Jul 1;169(1):99-107. doi: 10.4049/jimmunol.169.1.99. J Immunol. 2002. PMID: 12077234

9

Expression, Purification and Characterization of Ricin vectors used for exogenous antigen delivery into the MHC Class I presentation pathway.

Smith DC, Marsden CJ, Lord JM, Roberts LM. Smith DC, et al. Biol Proced Online. 2003;5:13-19. doi: 10.1251/bpo42. Epub 2003 Feb 17. Biol Proced Online. 2003. PMID: 12734560 Free PMC article.

10

Glycosphingolipids as toxin receptors.

Smith DC, Lord JM, Roberts LM, Johannes L. Smith DC, et al. Semin Cell Dev Biol. 2004 Aug;15(4):397-408. doi: 10.1016/j.semcdb.2004.03.005. Semin Cell Dev Biol. 2004. PMID: 15207830 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,042 results

Search Page

Filters